Technical Analysis for MITO - Stealth BioTherapeutics Corp.

Grade Last Price % Change Price Change
C 1.71 -6.04% -0.11
MITO closed down 6.04 percent on Thursday, February 25, 2021, on approximately normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical MITO trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
200 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Golden Cross Bullish -6.04%
1,2,3 Pullback Bullish Bullish Swing Setup -6.04%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.04%
Older End-of-Day Signals for MITO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 7 hours ago
Down 2 % about 7 hours ago
Down 1% about 7 hours ago
Fell Below Previous Day's Low about 7 hours ago
Up 3% 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related mitochondrial diseases. The company's product candidates include SBT-20, a small peptide that targets and binds reversibly to cardiolipin, stabilizing mitochondrial structure, and function under conditions of oxidative stress; and SBT-272, a lead discovery pipeline compound, evaluating for rare neurodegenerative diseases, such as amyotrophic lateral sclerosis. Stealth BioTherapeutics Corp was founded in 2006 and is based in Newton, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Diseases Dysfunction Degenerative Disease Peptides Degenerative Diseases Amyotrophic Lateral Sclerosis Neurodegenerative Diseases Neurodegeneration Senescence Oxidative Stress Mitochondria

Is MITO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.0
52 Week Low 0.9002
Average Volume 579,268
200-Day Moving Average 1.67
50-Day Moving Average 1.68
20-Day Moving Average 1.92
10-Day Moving Average 2.02
Average True Range 0.17
ADX 34.99
+DI 23.72
-DI 27.96
Chandelier Exit (Long, 3 ATRs ) 2.06
Chandelier Exit (Short, 3 ATRs ) 1.98
Upper Bollinger Band 2.45
Lower Bollinger Band 1.39
Percent B (%b) 0.3
BandWidth 54.94
MACD Line 0.07
MACD Signal Line 0.12
MACD Histogram -0.0522
Fundamentals Value
Market Cap 85.32 Million
Num Shares 49.9 Million
EPS -6.67
Price-to-Earnings (P/E) Ratio -0.26
Price-to-Sales 2.67
Price-to-Book 28.96
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.00
Resistance 3 (R3) 2.00 1.91 1.95
Resistance 2 (R2) 1.91 1.84 1.91 1.93
Resistance 1 (R1) 1.81 1.79 1.77 1.81 1.92
Pivot Point 1.72 1.72 1.70 1.72 1.72
Support 1 (S1) 1.62 1.65 1.58 1.62 1.50
Support 2 (S2) 1.53 1.60 1.53 1.49
Support 3 (S3) 1.43 1.53 1.47
Support 4 (S4) 1.43